Dr. Haruhiro Inoue is a world-renowned surgeon and endoscopist. He is a professor at Showa University School of Medicine and Chairman of the Digestive Disease Center at Showa
University Koto Toyosu Hospital in Tokyo, Japan.
Dr. Inoue graduated from Yamaguchi University School of Medicine in 1983. He completed a residency in General Surgery at Tokyo Medical and Dental University, and remained on the faculty at the university and its afﬁliated hospitals for more than 13 years. During this time, he served on the Japanese Board of Surgery, Gastrointestinal Surgery, and Endoscopic Surgery. In 2009, he was promoted to a full professor at Showa University, where he served as a chair of the Showa University International Training Center for Endoscopy and Surgical endoscopy (SUITES). In 2014, he moved Showa University Koto Toyosu Hospital and serve as a professor and chair of Digestive Diseases Center.
Dr. Inoue’s clinical achievements are wide-ranging. In 1992, he developed a technique (cap-EMR) that simpliﬁed the performance of endoscopic mucosal resection (EMR). In 2000, he reported the world’s ﬁrst EMR for Barrett’s intramucosal cancer, and in 2003, he again reported a circumferential EMR for Barrett’s esophagus with high grade dysplasia. This also recognized as the ﬁrst clinical report of antireflux mucosectomy (ARMS). In 2008, he performed the world’s ﬁrst clinical case of per-oral endoscopic myotomy (POEM), and to date his team has treated more than 2100 achalasia patients with the POEM procedure. In 2014, he reported the endoscopic removal of a submucosal tumor (SMT) using a POEM-like procedure, per-oral endoscopic tumor resection (POET). Also in 2014, he reported the ARMS procedure for PPI-resistant GERD. Now it advanced as antireflux mucosal ablation (ARMA). In 2019, he reported POEM+F (POEM+fundoplication) as a pure NOTES surgery for PPI refractory GERD.
Dr. Inoue is an honorary member of the Russian Society of Endoscopy, and the German Society of Radiology and Digestive Endoscopy. In 2008, he has become a Fellow of ASGE, and he was honored twice with the society’s Crystal award (2006 and 2013). In 2011, he received the Pioneer in Endoscopy Award from the Society of American gastrointestinal and endoscopic Surgeons (SAGES). In 2017, he received the Bushell Lecture Award from Australian society of gastroenterology. He is a long-term full member of ISDE.
Flexible endoscopic surgery 2021
Recently marked advancement of technology allows completing conventional surgery using flexible endoscopy. Laparoscopic Heller-Dor surgery can be done now by transoral flexible endoscopic surgery. This is POEM (Peroral endoscopic myotomy) for esophageal achalasia.
World first case was done in 2008, more than 2200 consecutive cases received POEM in our hospital. As offshoots of POEM, POET (Peroral endoscopic tumor resection), G-POEM (Gastric POEM) for gastroparesis, Z-POEM (Zenker POEM) were developed and clinically well accepted. In these procedures, submucosal tunnel is commonly created and then each surgical procedure is completed. Like this way, flexible endoscopic surgery brings us minimally invasive surgery with no visible scar on our skin. In this lecture we would like to show you a clinical series of flexible endoscopic surgery and discuss future of it.